|
Tweet | ||
368 * ! | Tue, 8/11/2015, 10:30 AM - 12:20 PM | CC-616 | |
Longitudinal Analysis — Contributed Papers | |||
Biopharmaceutical Section , Biometrics Section | |||
Chair(s): T. Ceesay, Merck | |||
10:35 AM | Making Better Dose Decisions — Zachary Skrivanek, Eli Lilly and Company | ||
10:50 AM | Two-Stage Approach to Evaluate Cardiovascular Risk of New Anti-Diabetic Therapies — Raymond Lam, Merck ; Shailaja Suryawanshi, Merck | ||
11:05 AM | A New Durability Analysis Method in Clinical Studies — John Xie, Johnson & Johnson ; Gordon Law, Johnson & Johnson ; Norm Bohidar, Johnson & Johnson ; Surya Mohanty, Johnson & Johnson ; Jiahui Li, Celgene Corporation | ||
11:20 AM | Joint Modeling of Longitudinal Responses and Survival Outcomes in Latent Class Framework — Yue Liu, Merck ; Lei Liu, Northwestern University ; Jianhui Zhou, University of Virginia | ||
11:35 AM | Assessing Association Between the Risk of Clinical Outcome Event and Patient's Disease Status That Vary by Time — Yiran Hu ; Bo Fu, AbbVie ; Yuanyuan Tang, AbbVie | ||
11:50 AM | On Two-Sample McNemar Test — Jim Xiang, Ortho McNeil Pharmaceutical | ||
12:05 PM | Methods of Assessing Treatment Failure or Response with Informative Censoring — Jun Zhao, AbbVie ; Qi Tang, AbbVie ; Bo Fu, AbbVie ; Claire L. Tsao, AbbVie |
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.